Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Biomarker Study in Endocrine Neoplasms to Study Acquired Resistance to Alkylator Chemotherapy

NCT07121998 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT07121998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Biomarker Study in Endocrine Neoplasms to Study Acquired Resistance to Alkylator Chemotherapy
Lead sponsor
Uppsala University
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
March 1, 2030
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine cancer, neuroendocrine (ne) tumors